series-b
Stage
2015
Founded
3
Investors
About
EnteroBiotix is a clinical-stage biotechnology company developing orally administered microbiome therapeutics for the treatment of gastrointestinal tract and liver diseases, including irritable bowel syndrome and liver cirrhosis.
Explore EnteroBiotix's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.